Skip to main content
Commonwealth of Virginia branding bar cardinal logo

Virginia.gov

A design prototype by Datopian, not an official website

Find a Commonwealth Resource

Enasidenib mesylate

HealthData.Gov

Updated Oct 29, 2026

About this dataset

Idhifa (enasidenib mesylate) is a prescription oral tablet that inhibits the IDH2 enzyme, used to treat adults with relapsed or refractory acute myeloid leukemia (AML) who have an IDH2 mutation. Available in 50mg and 100mg strengths. This information was generated using AI and is provided for informational and research purposes only.

Data and resources (1)

  • HTML

    Enasidenib mesylate

    Access the FDA dataset for Enasidenib mesylate — ANDA 209606 submitted by Mylan Institutional LLC

    Modified Jun 29, 2026

Prototype by Datopian · not an official government website · data from data.virginia.gov